QCompass

In this week’s update on the COVID-19 vaccination update, we discuss the latest from the CDC, week 3 of the Federal Retail Pharmacy Partnership and Reporting requirements, and how pharmacies should begin to clean up patient demographics to help for easier reporting.

Wintry weather across most of the country is impacting the delivery of COVID-19 vaccines to pharmacies, the National Governors Association is sending a letter to federal leaders, and the soft rollout of the Federal Retail Pharmacy Partnership are just a few of the topics in this week's RedSail Technologies' COVID-19 vaccination update.

QS/1 will release Service Pack 19.1.34 for NRx soon. It includes the new RedSail Technologies Patient Chart. Zach Princell, Pharm.D. and Assistant Product Manager, tells us more on how the new patient chart can help pharmacies as well as a few other of the new features included in the enhancements in the new service pack.

In this week's COVID-19 vaccination update, we discuss reporting requirements that have been updated for several states, who will control decisions in the coming vaccine phases, and how pharmacies can help senior citizens navigate technology to sign-up for the COVID-19 vaccination registration.

Pharmacies and LTC operations continue to tackle challenges as the first phases of the CDC COVID-19 vaccine ramp up. This week, David Pope, Pharm.D., chief innovation officer for OmniSYS and Ed Vess, R.Ph. RedSail Technologies' director of professional pharmacy affairs talk about what pharmacists need to do to get ready for implementation of the next phase as well as educating patients about potential vaccine scams that are already being reported. If you have questions for Ed or David,...

In this week's RedSail Technologies COVID-19 vaccine update, Ed Vess, R.Ph, director of professional pharmacy affairs, and David Pope, Pharm.D., chief innovation officer for OmniSYS, discuss changes on what pharmacies need to report, pressure from the CDC to ramp up the number of vaccinations administered, and the push to show pharmacies can make the difference in delivering those vaccines.

With 2021 underway, COVID-19 vaccination of frontline workers continues. But as independent pharmacies gear up to administer the vaccine, Ed Vess and David Pope have the latest on what you need to know in the first episode of our third season!

In this week's COVID-19 vaccination update, Ed Vess and David Pope discuss federal vs state guidelines, states making reporting information changes, and how COVID-19 is helping the effort to grant provider status to pharmacists.

RedSail Technologies announced the acquisition of PioneerRx®, becoming the largest community-focused pharmacy network in the country. RedSail Technologies CEO Kraig McEwen talks about how this move will better position community pharmacy for the future.

By a vote of 17-4, an FDA advisory panel recommended the agency give emergency use authorization to the Pfizer COVID-19 vaccine. RedSail Technologies' Ed Vess and David Pope from OmniSYS discuss the latest information as we get closer to community pharmacies and long-term care operations administering the COVID-19 vaccine to the public.

With two COVID-19 vaccines close to getting EUA from the U.S. Food and Drug Administration, RedSail Technologies continues to update CDC discussions about distribution across the country. This week we talk to RedSail Technologies' Ed Vess, R.Ph., David Pope, PharmD, from OnmiSYS, and ASCP's Chad Worz, PharmD, and Arnie Clayman, PD, about the latest details.

Two pharmaceutical companies are on the cusp of asking for Emergency Use Authorization from the FDA for distribution of a COVID-19 vaccination. Get the latest on Operation Warp Speed with our guests Ed Vess and David Pope on this week's QCompass.

QS/1 is excited to share the news that a new sales representative will now serve our customers in the western region. Jerry Grannis has 22 years of experience with Rx30 and a deep knowledge of the area’s independent pharmacy landscape. Reach him via email at Jerry.Grannis@redsailtechnologies.com or via mobile phone at 909.732.1301.

In our weekly update on Operation Warp Speed from the CDC, RedSail Technologies' Ed Vess, R.Ph., and David Pope, Pharm.D., chief innovation officer for OmniSYS, tell us about how fields from pharmacies will be reported and more on federal partnerships.

Busy pharmacists rely on NRx to handle everything a day brings. It’s a complete solution built with decades of experience in the tools and integrations community pharmacists need. QS/1's Brian Sullivan talks about its streamlined workflow, modern health tools, flexible patient service, and how pharmacies can make sure they are getting all of the performance available.Visit www.qs1.com/nrx for more details.

Ed Vess, R.Ph, QS/1®director of professional pharmacy affairs and OmniSYS® chief innovation officer David Pope, Pharm.D., discuss registering as a mass immunizer vs. a pharmacy immunizer and an update on allocation once a COVID-19 vaccine is approved in this week's update.

Pharmacies and LTC operations are learning the reimbursement fees that will be paid when administering COVID-19 vaccines. Ed Vess, R.Ph., director of pharmacy professional affairs for RedSail Technologies and David Pope, Pharm. D., chief innovation officer for OmniSYS® give us the fourth update from the CDC on a COVID-19 vaccination.

Ed Vess, R.Ph., director of pharmacy professional affairs for RedSail Technologies and David Pope, Pharm.D., chief innovation officer for OmniSYS® give us the third update from the CDC on a COVID-19 vaccination that will be given out in pharmacies and long-term care operations.

Late last Friday, HHS announced a partnership with two chain pharmacies to deliver COVID-19 vaccine options to LTC facilities. It is important to note the program is not limited to these pharmacies. Independent pharmacies are still critical to the success of the program, especially in rural and medically under served areas. Our Ed Vess, R.Ph., director of professional pharmacy affairs, discusses the misinformation and confusion this announcement is causing.

The CDC continues its weekly update for pharmacies in preparation of a COVID-19 vaccination. Our own Ed Vess, director of Pharmacy Professional Affairs, and OmniSYS® Chief Innovation Officer David Pope sit down with us on the latest information from this update.